The FTC, which enforces consumer protection laws against fraud and deceptive business practices, issued 20 warning letters to companies and individuals for allegedly making "unsubstantiated" claims that their products could prevent or treat the disease. Among the FTC's targets are several companies and medical practices that marketed an injectable drug called thymosin alpha-1 as a purported treatment for COVID-19.